GoodRx and Weight Watchers to Offer Ozempic Pill
By Katherine Hamilton
GoodRx and Weight Watchers both separately announced on Friday that they will start offering weight-loss pills.
GoodRx, which gives users access to coupons on pharmaceuticals, said it is expanding access to Novo Nordisk's Ozempic pill for eligible patients with type 2 diabetes.
The 1.5 milligram pill will be priced at $149 a month, with the 4mg pill costing $199 and 9mg costing $299, GoodRx said.
Separately, WW International, or Weight Watchers, said it will start offering the Ozempic pill through Med+, its subscription program that pairs weight-loss drugs with nutritional and behavioral support for weight loss.
The pill will be for people with type 2 diabetes and joins the injectable GLP-1s already available via Med+.
Novo Nordisk said Friday it would make the Ozempic pill available starting May 4. The Food and Drug Administration approved the pill form of the drug in February.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
May 01, 2026 08:52 ET (12:52 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
United States